Hsieh TY - Search Results

1

Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir.

Wang CC, Tseng KC, Peng CY, Hsieh TY, Lin CL, Su TH, Tseng TC, Hsu CS, Lin HH, Kao JH. Wang CC, et al. Among authors: hsieh ty. J Gastroenterol Hepatol. 2013 Jan;28(1):46-50. doi: 10.1111/j.1440-1746.2012.07269.x. J Gastroenterol Hepatol. 2013. PMID: 22989322

2

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

Liu CJ, Lai MY, Chao YC, Liao LY, Yang SS, Hsiao TJ, Hsieh TY, Lin CL, Hu JT, Chen CL, Chen PJ, Kao JH, Chen DS. Liu CJ, et al. Among authors: hsieh ty. Hepatology. 2006 Apr;43(4):742-9. doi: 10.1002/hep.21100. Hepatology. 2006. PMID: 16557544 Clinical Trial.

3

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients.

Peng CY, Hsieh TC, Hsieh TY, Tseng KC, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. Peng CY, et al. Among authors: hsieh ty, hsieh tc. J Formos Med Assoc. 2015 Apr;114(4):308-13. doi: 10.1016/j.jfma.2013.10.023. Epub 2013 Dec 5. J Formos Med Assoc. 2015. PMID: 24315616 Free article.

4

Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B.

Chien RN, Peng CY, Kao JH, Hu TH, Lin CC, Hu CT, Chen CY, Hsieh TY, Lin HC, Chuang WL; Taiwan NA-Registry Group. Chien RN, et al. Among authors: hsieh ty. J Gastroenterol Hepatol. 2014 Jan;29(1):185-92. doi: 10.1111/jgh.12416. J Gastroenterol Hepatol. 2014. PMID: 24354995

5

Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan.

Wang CC, Lin CL, Hsieh TY, Tseng KC, Peng CY, Su TH, Yang SS, Hsu YC, Chen TM, Kao JH. Wang CC, et al. Among authors: hsieh ty. Hepatol Int. 2016 Mar;10(2):294-301. doi: 10.1007/s12072-015-9662-9. Epub 2015 Sep 23. Hepatol Int. 2016. PMID: 26399763

6

Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues.

Tseng KC, Tseng CW, Hsieh TY, Peng CY, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. Tseng KC, et al. Among authors: hsieh ty. Hepatol Res. 2016 Jun;46(7):642-9. doi: 10.1111/hepr.12600. Epub 2015 Nov 2. Hepatol Res. 2016. PMID: 26422680 No abstract available.

7

Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg.

Wang CC, Tseng KC, Hsieh TY, Tseng TC, Lin HH, Kao JH. Wang CC, et al. Among authors: hsieh ty. Am J Gastroenterol. 2016 Sep;111(9):1286-94. doi: 10.1038/ajg.2016.109. Epub 2016 Apr 5. Am J Gastroenterol. 2016. PMID: 27045923

8

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

Su TH, Hu TH, Chen CY, Huang YH, Chuang WL, Lin CC, Wang CC, Su WW, Chen MY, Peng CY, Chien RN, Huang YW, Wang HY, Lin CL, Yang SS, Chen TM, Mo LR, Hsu SJ, Tseng KC, Hsieh TY, Suk FM, Hu CT, Bair MJ, Liang CC, Lei YC, Tseng TC, Chen CL, Kao JH; C-TEAM study group and the Taiwan Liver Diseases Consortium. Su TH, et al. Among authors: hsieh ty. Liver Int. 2016 Dec;36(12):1755-1764. doi: 10.1111/liv.13253. Epub 2016 Oct 4. Liver Int. 2016. PMID: 27634134

9

Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study.

Chen YJ, Chen KW, Shih YL, Su FY, Lin YP, Meng FC, Lin F, Yu YS, Han CL, Wang CH, Lin JW, Hsieh TY, Li YH, Lin GM. Chen YJ, et al. Among authors: hsieh ty. World J Gastroenterol. 2017 Jul 7;23(25):4587-4594. doi: 10.3748/wjg.v23.i25.4587. World J Gastroenterol. 2017. PMID: 28740347 Free PMC article.

10

Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan.

Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH. Liu CH, et al. Among authors: hsieh ty. Aliment Pharmacol Ther. 2018 Dec;48(11-12):1290-1300. doi: 10.1111/apt.15011. Epub 2018 Oct 25. Aliment Pharmacol Ther. 2018. PMID: 30362139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

413 results

Search Page